HomeInsights
INDUSTRY:
Pharma
TOPIC:
Business & People, Manufacturers & Providers
TITLE:
US ICER: New pricing for Entreso from Novartis
BRIEF:
The ICER (Institute for Clinical and Economic Review) issued results for the cost-effective analysis for the new heart failure drug
LEGAL IMPLICATIONS:
BUSINESS IMPLICATIONS:
